Abstract
The influence of estrogen therapy on changes in arthritis and bone mineral density (BMD) was evaluated using an estrogen-replete collagen-induced arthritis (CIA) rat model. Seven-month-old female Sprague–Dawley rats (n = 30) were divided into the three groups; control (CONT), collagen sensitization (CIA), and CIA + 17β-estradiol administration for 7 weeks (CIA + E). BMD was measured by peripheral quantitative computed tomography in the proximal tibia every 2 weeks. Eight weeks after the initial sensitization the rats were killed and histomorphometry of tibia was performed. The hind paw thickness increased with time in CIA rats and there was a significant difference between CONT and CIA at 8 weeks after the initial sensitization. Estrogen tended to make the development of arthritis milder. In CIA, BMD at metaphyseal cancellous bone began to decrease with the onset of arthritis and became significantly lower than in CONT after 8 weeks. Compared with the CIA, the deterioration in BMD was inhibited in CIA + E. Histomorphometrical parameters of bone resorption were increased in CIA compared with CONT, and those elevations were reduced by estrogen treatment, but estrogen had no effect on bone formation parameters. In conclusion, estrogen could partially suppress arthritis and bone loss in estrogen-replete rats as well as estrogen-deplete ones.
Similar content being viewed by others
References
Saville PD, Kharmosh O. Osteoporosis of rheumatoid arthritis: influence of age, sex and corticosteroids. Arthritis Rheum. 1967;10:423–30.
Wronski TJ, Cintron M, Doherty AL, Dann LM. Estrogen treatment prevents osteopenia and depresses bone turnover in ovariectomized rats. Endocrinology. 1988;123:681–6.
Teshima R, Yamamoto K, Kishimoto H, Morio Y, Hagino H, Maeyama I. Osteoporotic changes in rheumatoid arthritis. J Jpn Orthop Assoc. 1987;61:289–97.
Reid DM, Kennedy NS, Smith MA, Tothill P, Nuki G. Total body calcium in rheumatoid arthritis: effects of disease activity and corticosteroid treatment. Br Med J. 1982;285:330–2.
Da Silva JA, Spector TD. The role of pregnancy in the course and aetiology of rheumatoid arthritis. Clin Rheumatol. 1992;11:189–94.
Heikkila R, Aho K, Heliövaara M, Knekt P, Reunanen A, Aromaa A, et al. Serum androgen-anabolic hormones and the risk of rheumatoid arthritis. Ann Rheum Dis. 1998;57:281–5.
Pritchard MH. An examination of the role of female hormones and pregnancy as risk factors for rheumatoid arthritis, using a male population as control group. Br J Rheumatol. 1992;31:395–9.
Yamasaki D, Enokida M, Okano T, Hagino H, Teshima R. Effects of ovariectomy and estrogen replacement therapy on arthritis and bone mineral density in rats with collagen-induced arthritis. Bone. 2001;28:634–40.
Enokida M, Yamasaki D, Okano T, Hagino H, Morio Y, Teshima R. Bone mass changes of tibial and vertebral bones in young and adult rats with collagen-induced arthritis. Bone. 2001;28:87–93.
Yamane I, Hagino H, Okano T, Enokida M, Yamasaki D, Teshima R. Effect of minodronic acid (ONO-5920) on bone mineral density and arthritis in adult rats with collagen-induced arthritis. Arthritis Rheum. 2003;48:1732–41.
Kameyama Y, Hagino H, Okano T, Enokida M, Fukata S, Teshima R. Bone response to mechanical loading in adult rats with collagen-induced arthritis. Bone. 2004;35(4):948–56.
Fukata S, Hagino H, Okano T, Yamane I, Kameyama Y, Teshima R. Effect of intermittent administration of human parathyroid hormone on bone mineral density and arthritis in rats with collagen-induced arthritis. Arthritis Rheum. 2004;50(12):4060–9.
Gasser JA. Assessing bone quantity by pQCT. Bone. 1995;17:145S–54 (Suppl).
Villanueva AR, Lundin KD. A versatile new mineralized bone stain for simultaneous assessment of tetracycline and osteoid seams. Stain Technol. 1989;64(3):129–38.
Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. J Bone Miner Res. 1987;2(6):595–10.
Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagens: an experimental model of arthritis. J Exp Med. 1977;146:857–68.
Arend WP, Dayer JM. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis. Arthritis Rheum. 1995;38:151–60.
Fujimoto M, Hayasida K, Ochi T, Owaki H, Shimaoka Y, Okamura M, et al. Fluctuation of interleukin-1 and -6 activity in bone marrow serum in collagen-induced arthritis in rats. Biomed Res. 1992;13:243–51.
Harris ED Jr. Rheumatoid arthritis pathophysiology and implications for therapy. N Engl J Med. 1990;322:1277–89.
Jansson L, Olsson T, Holmdahl R. Estrogen induces a potent suppression of experimental autoimmune encephalomyelitis and collagen-induced arthritis in mice. J Neuroimmunol. 1994;53:203–7.
Vandenbroucke JP, Valkenburg HA, Boersma JW, Cats A, Festen JJ, Huber-Bruning O, et al. Oral contraceptives and rheumatoid arthritis: further evidence for a preventive effect. Lancet. 1982:2(8303):839–42.
Wingrave SJ, Kay CR. Reduction in incidence of rheumatoid arthritis associated with oral contraceptives. Lancet. 1978;1(8064):569–71.
Cevik R, Em S, Gur A, Nas K, Sarac AJ, Colpan L. Sex and thyroid hormone status in women with rheumatoid arthritis: are there any effects of menopausal state and disease activity on these hormones? Int J Clin Pract. 2004;58(4):327–32.
Cutolo M, Balleari E, Giusti M, Monachesi M, Accardo S. Sex hormone status in women suffering from rheumatoid arthritis. J Rheumatol. 1986;13(6):1019–23.
Jansson L, Holmdahl R. Oestrogen-induced suppression of collagen arthritis; 17 beta-oestradiol is therapeutically active in normal and castrated F1 hybrid mice of both sexes. Clin Exp Immunol. 1992;89(3):446–51.
Esposito E, Iacono A, Raso GM, Pacilio M, Coppola A, Di Carlo R, et al. Raloxifene, a selective estrogen receptor modulator, reduces carrageenan-induced acute inflammation in normal and ovariectomized rats. Endocrinology. 2005;146(8):3301–8.
Oursler MJ, Osdoby P, Pyfferoen J, Riggs BL, Spelsberg TC. Avian osteoclasts as estrogen target cells. Proc Natl Acad Sci USA. 1991;88:6613–7.
Acknowledgments
This study was partially supported by a grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (17591573). We would like to express our sincere thanks to Akemi Ito for her help in preparing sections and staining, and to Masaru Kuwamoto, Satoru Fukata, and Shinji Tanishima for their help in carrying out this experiment.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Yoshioka, T., Hagino, H., Yamasaki, D. et al. Effect of estrogen replacement therapy on arthritis and bone mineral density in estrogen-replete rats with collagen-induced arthritis. Mod Rheumatol 18, 23–28 (2008). https://doi.org/10.1007/s10165-007-0011-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10165-007-0011-2